COVID-19 vaccination speed and equity; “DIR fee” reform; organized retail crime among key topics for virtual advocacy March 3-4.
On June 24, the NACDS Board of Directors “virtually” met with eight key members of the Administration and Congress.
Due to developments this morning, actual and potential changes in Congress’ response to COVID-19 make it appropriate to cancel the 2020 NACDS RxIMPACT Day on Capitol Hill.
A record-breaking 57 campuses will be represented by 60 student pharmacists at the 2020 NACDS RxIMPACT Day on Capitol Hill.
Many recent NACDS RxIMPACT pharmacy tours have been directly with members of Congress themselves—68 percent so far this year.
The total number of NACDS RxIMPACT 2019 in-district events to promote DIR relief priorities now stands at 72—and counting.
Members of Congress were able to grasp firsthand critical pharmacy public policy issues when they toured pharmacies in their home states and congressional districts.
During the Fourth of July congressional recess, members of Congress learned firsthand about key pharmacy issues—particularly about the need for direct and indirect remuneration (DIR) fee relief as part of a drug-pricing legislative package.
DIR fee relief is motivating a record-breaking NACDS RxIMPACT Congressional letter-writing campaign. The effort to end the abuse of DIR fees includes three focuses right now. Learn more.
NACDS RxIMPACT's largest grassroots initiative ever has led to pharmacy advocates sending more than 4,700 letters to Congress--to date--urging DIR reform.
